SummaryThere are many technics for treating condyloma acuminatum. None is entirely satisfactory. The viral etiology and the probable venereal transmission make most methods difficult at best. Our method of using bichloracetic acid has given us a more satisfactory cure rate, with a minimum of discomfort, no scarring, and less prolonged convalescence. Future improvement in the management of condyloma acuminatum will depend upon the development of a suitable vaccine based on the positive identification of these growths as specific infectious lesions caused by a virus. Oral or injectable medication would attack the lesion directly, be easier to apply, be less painful, and allow vectors to be treated more easily. However, until such a vaccine is introduced, the clinician will continue to see condyloma acuminatum and will need therapeutic tools that cause few complications and minimum discomfort and have a reasonable degree of success in removing the warts.